Additionally, all tumors demonstrated somatic loss of expression in one of the four mismatch repair proteins (MSH2, MSH6, MLH1, or PMS2) resulting in mismatch repair deficiency. The gene discussed is MLH1; the disease is mismatch repair cancer syndrome 1.